Mcl-1 has been identified as a Bcr-Abl-dependent target and survival factor in CML cells [40], [41], and its up-regulation has been shown to play an important role in resistance to apoptosis [42]. Here, MCL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.